20 |
Screening and Diagnostic Technology in NTEP |
29/01/2022 |
|
60 |
Close Contacts of a TB Case |
29/01/2022 |
|
343 |
Overcrowding |
29/01/2022 |
|
96 |
Mode of TB Transmission |
29/01/2022 |
|
345 |
Source of TB infection |
29/01/2022 |
|
346 |
Poor ventilation |
29/01/2022 |
|
348 |
Air exchanges per Hour |
29/01/2022 |
|
347 |
Poor host immunity |
29/01/2022 |
|
353 |
Global Burden of DR-TB |
29/01/2022 |
|
129 |
Global Burden of TB |
29/01/2022 |
|
356 |
Global Burden of TB-HIV |
29/01/2022 |
|
50 |
Health System Integration |
30/01/2022 |
|
102 |
National Institutes |
30/01/2022 |
|
104 |
The State TB Cell |
30/01/2022 |
|
380 |
Norms and requirements of a DMC |
30/01/2022 |
|
143 |
NAAT Labs and their role |
30/01/2022 |
|
23 |
General process flow for testing in NTEP |
30/01/2022 |
|
145 |
Principles of TB Diagnosis under NTEP |
30/01/2022 |
|
396 |
CBNAAT Xpert Ultra Assay/Cartridge |
09/02/2022 |
|
12 |
Stages in TB Patient's Lifecycle |
13/02/2022 |
|
314 |
Nomenclature of Mycobacterium tuberculosis [M.tb] |
14/02/2022 |
|
63 |
Phenotypic Tests |
16/02/2022 |
|
192 |
General Concepts in Microscopy quality assurance |
16/02/2022 |
|
193 |
EQA for Microscopy LTs |
16/02/2022 |
|
64 |
Genotypic Tests |
16/02/2022 |
|
144 |
Sputum Collection centres |
16/02/2022 |
|
24 |
Request for TB tests |
17/02/2022 |
|
510 |
TB Infection Vs Active TB Disease |
06/03/2022 |
|
513 |
Drug-resistant Tuberculosis |
06/03/2022 |
|
94 |
Risk Factors for TB Disease |
10/03/2022 |
|